CAMBRIDGE, England, October 15, 2013 /PRNewswire/ --
Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces positive results from its Phase II study of APD515 for the treatment of xerostomia (dry mouth) in advanced cancer patients.......
More...
